






GHK-Cu
50mg
85.00$
GHK-Cu is studied for its role in tissue regeneration, collagen synthesis, and cellular repair signaling. Research models often explore how this peptide influences wound healing processes, skin remodeling, and anti-inflammatory responses.
GHK-Cu
Product Name: GHK-Cu
Type: Tissue Regeneration Research Peptide
Research Focus:
GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper peptide with documented roles in wound healing, tissue remodeling, and skin regeneration[1][2]. Research demonstrates activity in gene regulation related to collagen synthesis, antioxidant defense, and anti-inflammatory pathways[3][4]. This educational protocol presents practical subcutaneous administration approaches based on clinical practice patterns.
Research Interest:
- Collagen and extracellular matrix synthesis studies
- Skin regeneration and wound-healing models
- Anti-inflammatory signaling pathway research
- Hair follicle and tissue rejuvenation studies
Scientific Interest:
- Cellular repair mechanisms
- Tissue remodeling pathways
- Regenerative signaling networks
Reconstitution:
Reconstitute: Add 3.0 mL sterile water → 16.67 mg/mL concentration.
Typical range: 1.0–2.0 mg per injection (most common protocols use 5 days/week or 3×/week).
Easy measuring: At 16.67 mg/mL, 1 unit = 0.01 mL ≈ 167 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: store at −20 °C (−4 °F) or below; reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F)and use within 30 days.
Cycle:
Standard / Conservative Approach (3 mL = 16.67 mg/mL; 5 days/week)
WEEK/PHASE | DOSE PER INJECTION | UNITS (PER INJECTION) (ML) |
|---|---|---|
Weeks 1–4 | 1.0 mg (1000 mcg) | 6 units (0.06 mL) |
Weeks 5–8 | 1.5 mg (1500 mcg) | 9 units (0.09 mL) |
Weeks 9–12+ | 2.0 mg (2000 mcg) | 12 units (0.12 mL) |
Frequency: Inject once daily, 5 days per week subcutaneously[5][6]. This gradual titration allows assessment of individual tolerance while maintaining practical injection volumes. For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.
Reconstitution Steps
Draw 3.0 mL sterile or bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall to minimize foaming.
Gently swirl or roll the vial until the peptide fully dissolves (do not shake vigorously).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
IMPORTANT NOTICE:
This product is intended strictly for laboratory research. It is not intended to diagnose, treat, cure, or prevent any disease.

